Inotiv Inc
NASDAQ:NOTV

Watchlist Manager
Inotiv Inc Logo
Inotiv Inc
NASDAQ:NOTV
Watchlist
Price: 0.537 USD -4.47% Market Closed
Market Cap: 18.5m USD

Inotiv Inc
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Inotiv Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Inotiv Inc
NASDAQ:NOTV
Cash from Operating Activities
-$10.5m
CAGR 3-Years
-26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Cash from Operating Activities
$7.7B
CAGR 3-Years
-2%
CAGR 5-Years
2%
CAGR 10-Years
12%
Danaher Corp
NYSE:DHR
Cash from Operating Activities
$6.3B
CAGR 3-Years
-9%
CAGR 5-Years
4%
CAGR 10-Years
5%
Mettler-Toledo International Inc
NYSE:MTD
Cash from Operating Activities
$996.4m
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
9%
Agilent Technologies Inc
NYSE:A
Cash from Operating Activities
$1.5B
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
1%
IQVIA Holdings Inc
NYSE:IQV
Cash from Operating Activities
$2.8B
CAGR 3-Years
5%
CAGR 5-Years
9%
CAGR 10-Years
18%
No Stocks Found

Inotiv Inc
Glance View

Inotiv, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The company is headquartered in West Lafayette, Indiana and currently employs 541 full-time employees. The firm focuses on providing drug developers with scientific research and analytical instrumentation. The firm operates through two segments, including Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance and quality control testing. The Research Products segment offers two principal product lines, including analytical products and in vivo sampling products. Analytical products consist of liquid chromatographic and electrochemical instruments with associated accessories. In vivo sampling products consist of the Culex family of automated in vivo sampling and dosing instruments.

NOTV Intrinsic Value
Not Available

See Also

What is Inotiv Inc's Cash from Operating Activities?
Cash from Operating Activities
-10.5m USD

Based on the financial report for Sep 30, 2025, Inotiv Inc's Cash from Operating Activities amounts to -10.5m USD.

What is Inotiv Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-26%

Over the last year, the Cash from Operating Activities growth was -54%. The average annual Cash from Operating Activities growth rates for Inotiv Inc have been -26% over the past three years .

Back to Top